Study of expression of CD138 and heparinase in hepatocellular carcinoma by tissue microarray

Chinese Journal of Pathology

Volumn 35, Issue 2, 2006, Pages 82-86

  Lü, Zi Li ^a   Zhang, Wen Min ^a   Xiao, Gang ^a   Zhang, Meng ^a   Xie, Dan ^a   Xu, Fang Ping ^a   Liang, Xiu Jiu ^a   Bi, Shen Jin ^a   Wen, Jian Ming ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

CD138; Heparin lyase; Liver neoplasms

Indexed keywords

HEPARIN LYASE; SYNDECAN 1;

ARTICLE; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR GROWTH; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPARIN LYASE; HUMANS; LIVER; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PERITONEAL NEOPLASMS; PORTAL VEIN; SYNDECAN-1; TISSUE ARRAY ANALYSIS;

EID: 33344478029     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Yano H, Mazaki Y, Kurokawa K, et al. Roles played by a subset of integrin signaling molecules in cadherin-based cell-cell adhesion. J Cell Biol, 2004, 166:283-295.
2. Andersen NF, Standal T, Nielsen JL, et al. Syndecan-1 and angiogenic cytokines in multiple myeloma; correlation with bone marrow angiogenesis and survival. Br J Haematol, 2005, 128:210-217.
3. Nemeth Z, Szigeti K, Mathe M, et al. Effect of induction chemotherapy on changes of laminin and syndecan expression in oral squamous cell carcinomas; a prospective, randomized, clinicopathologic and immunohistochemical study. J Craniofac Surg, 2005, 16:205-212.
4. Tsanou E, Ioachim E, Briasoulis E, et al. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas, correlation with extracellular matrix components. J Exp Clin Cancer Res, 2004, 23:641-650.
5. Zellweger T, Ninck C, Bloch M, et al. Expression patterns of potential therapeutic targets in prostate cancer. Int J Cancer, 2005, 113:619-628.
6. Wang Z, Zhang X, Xu H, et al. Detection of peritoneal micrometastasis by reverse transcriptase-polymerase chain reaction for heparanse mRNA and cytology in peritoneal wash samples. J Surg Oncol, 2005, 90:59-65.
7. Sato T, Yamaguchi A, Goi T, et al. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis and prognosis. J Surg Oncol, 2004, 87:174-181.
8. Liu K, Lei XZ, Zhao LS, et al. Tissue microarray for high-throughput analysis of gene expression profiles in hepatocellular carcinoma. World J Gastroenterol, 2005, 11:1369-1372.
9. Hernandez BY, Frierson HF, Moskaluk CA, et al. CK20 and CK7 protein expression in colorectal cancer; demonstration of the utility of a population-based tissue microarray. Hum Pathol, 2005, 36:275-281.
10. Watari J, Saltoh Y, Fujiya M, et al. Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with high metastatic potential. J Gastroenterol, 2004, 39:104-112.
11. Matsumoto A, Ono M, Fujimoto Y, et al. Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential. Int J Cancer, 1997, 74:482-491.
12. Gingis-Velitski S, Zetser A, Kaplan V, et al. Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans. J Biol Chem, 2004, 279:44084-44092.